Regencell Bioscience Holdings RGC Ratios (2020-2025)

NASDAQ RGC
$6.20 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Regencell Bioscience Holdings Quarterly Ratios

Periods 7 quarters
Latest Dec 2025

Regencell Bioscience Holdings ratios data for the quarter ended Dec 2025. These financial ratios cover 7 quarters of results from Jun 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025 Dec2025
Efficiency
Assets AverageAssets Avg. 0.00B
Equity AverageEquity Avg. -0.00B0.01B0.01B0.01B0.01B0.00B
Invested CapitalInvested Cap. 3,069.91B-0.00B0.02B0.01B0.01B0.00B0.00B
Leverage & Solvency
Debt Ratio 0.01B0.000.000.00
Valuation
Price to BookP/B 0.690.660.1445.62224.11
Enterprise Value -0.00B0.02B-0.01B0.22B0.27B
Market Capitalization 0.01B0.01B0.00B0.22B0.27B

Regencell Bioscience Holdings Ratios API

Pull Regencell Bioscience Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGC&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY